| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-08-03 | NCT07741110 Biomarker Analysis Data From a Randomized Phase II Study in Patients With Nasopharyngeal… | Completed | |
| 2026-07-23 | NCT07723261 Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line… | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Not specified | |||
| NCT07066917 | Mechanisms of Response and Resistance to Innovative Treatments in Patients With Locally… | Metastatic Breast Cancer | Recruiting |
| NCT04985058 | Real-world Data in Patients With Breast Cancer Treated With Abemaciclib | Breast Cancer | Recruiting |
| NCT07723261 | Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line… | Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) | Recruiting |
| NCT06876402 | Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell… | NSCLC (Non-small Cell Lung Cancer) | Active, Not Recruiting |
| NCT07630558 | Investigation of the Prognostic Value of Patterns of Genomic Alterations or Protein… | Breast Cancer | Active, Not Recruiting |